secwatch.observer — SEC 8-K summary
======================================

Issuer:     Centessa Pharmaceuticals plc (CNTA)
CIK:        0001847903
Form:       8-K
Filed at:   2022-07-01T23:59:59+00:00
Accession:  0001847903-22-000040
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Centessa board adds ex-BMS regulatory exec; director Kantoff resigns
--------------------------------------------------------------------

- Aaron Kantoff resigned from Centessa board effective July 1, 2022; no disagreement cited, will remain as advisor.
- Mathias Hukkelhoven, former SVP Global Regulatory at BMS, appointed to board and Nominating & Governance Committee.
- Hukkelhoven receives initial option for 96,000 ordinary shares vesting over 3 years, plus annual grants of 48,000 shares.
- Dr. Hukkelhoven also serves on Compugen (CGEN) board and as advisor to McKinsey and LianBio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847903/000184790322000040/0001847903-22-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847903/000184790322000040/cnta-20220701.htm
  HTML page:      https://secwatch.observer/filing/0001847903-22-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer